Medicine and Dentistry
Patient
100%
Heart Failure
57%
Clinical Trial
50%
Heart
42%
Arm
35%
Vagus Nerve Stimulation
32%
Medical Device
32%
Ripasudil
32%
Retinopathy of Prematurity
27%
Brilliant Blue
22%
Ezetimibe
21%
Inpatient
19%
Exercise
19%
Adverse Event
19%
Stimulation
18%
Therapeutic Procedure
16%
Mitral Insufficiency
16%
Informed Consent
16%
Antiphospholipid Antibody
16%
Acid
16%
Membrane
16%
Statin
16%
Cardiology
16%
Anaerobic Threshold
16%
Learning
15%
Hydrocortisone Release
14%
Cushing Syndrome
14%
Plaque
14%
Surgery
13%
Vitrectomy
13%
Development
12%
Combination Therapy
12%
Collagen
12%
Evaluation Study
12%
Male
12%
Endothelial Dysfunction
11%
Dependent Personality Disorder
11%
Coronary Stenting
11%
Oxysterol
11%
Ejection Fraction
10%
Eye Drops
10%
Medical Technology
10%
Association
10%
Follow up
10%
Left Ventricle
9%
Magnetic Stimulation
9%
Coil
9%
Acute Heart Infarction
9%
Female
9%
Neuron
9%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
71%
Warfarin
50%
Liver Cirrhosis
49%
Chronic Thromboembolic Pulmonary Hypertension
45%
Adverse Event
39%
Hepatitis C Virus
33%
Deterioration
32%
Direct Oral Anticoagulant
29%
Tolerability
20%
Amyotrophic Lateral Sclerosis
19%
Hepatitis B Virus
19%
Dog
19%
Rat
18%
Isoprenaline
18%
Statin (Protein)
18%
Group Trial
18%
Phosphodiesterase Inhibitor
16%
Levosimendan
16%
Disease Exacerbation
16%
Ripasudil
16%
Pitavastatin
16%
Prospective Cohort Study
16%
Heart Failure
16%
Diseases
15%
Catenin
15%
Congestive Heart Failure
14%
Human
12%
Bleeding
11%
Chloride
10%
Pyridine
10%
Glucopyranosyl Lipid A
10%
Eye Drops
10%
Retrolental Fibroplasia
10%
Anticoagulant Agent
10%
Ezetimibe
10%
Pharmacokinetics
10%
Indicator
9%
Antivitamin K
9%
Nausea
9%
Prognosis
8%
Placebo
8%
Cushing Syndrome
8%
Oxygen
8%
Clinical Feature
8%
Oxygen
7%
Calcium
7%
Prematurity
7%
Mortality
7%
Morbidity
7%
Heart Failure
6%
Biochemistry, Genetics and Molecular Biology
Volume
38%
Association
24%
Clinical Trial
21%
Length
21%
Oxysterol
20%
Statin
20%
Dose
19%
Hepatitis C Virus
19%
Hepatitis B Virus
19%
Exercise
19%
Collagen
18%
Cyclic Adenosine Monophosphate
16%
Energy
16%
Cholesterol Metabolism
16%
Structure Analysis
16%
Compliance (Physical)
16%
Pressure
16%
Learning
15%
Dog
14%
Cholesterol
13%
Catenin
13%
Absorption
12%
Calcium Cell Level
12%
Calcium
12%
Impedance
11%
Rigidity
11%
Time
9%
Heart Left Ventricle Function
8%
Ultrasound
8%
Aequorin
8%
Strength
8%
Contrast
8%
Campesterol
7%
Synthesis
7%
Serum Albumin
6%
Albumin Level
6%
Mortality
6%
27-Hydroxycholesterol
6%
Heart Ventricle Enddiastolic Pressure
6%
Rat
6%
Solution and Solubility
6%
Perfusion
6%
Stakeholder Engagement
5%
